Correction: Patterns of Weight Change Following the Cessation of Anti-Obesity Medications
-
By
-
Han Wu
-
Wenjia Yang
-
Tong Guo
-
Xiaoling Cai
-
Linong Ji
-
March 25, 2026
-
Clinical Scorecard: Correction: Patterns of Weight Change Following the Cessation of Anti-Obesity Medications
At a Glance
| Category | Detail |
|---|
| Condition | Weight Regain After Discontinuation of Anti-Obesity Medications |
| Key Mechanisms | Longitudinal analysis of weight change trends post-medication cessation. |
| Target Population | Individuals who have been treated with anti-obesity medications. |
| Care Setting | Clinical settings involving weight management and obesity treatment. |
Key Highlights
- General trend of weight regain following drug discontinuation confirmed.
- Utilized multilevel modeling to analyze longitudinal data.
- Sensitivity analysis excluded studies with potential bias.
- No significant difference in weight regain between placebo and active controls.
- Data transparency maintained through summary data extraction.
Guideline-Based Recommendations
Diagnosis
- Assess weight change patterns post anti-obesity medication cessation.
Management
- Consider the risk of weight regain when discontinuing anti-obesity medications.
Monitoring & Follow-up
- Regularly monitor weight and BMI after cessation of treatment.
Risks
- Potential for significant weight regain following discontinuation.
Patient & Prescribing Data
Patients previously treated with anti-obesity medications.
Weight management strategies should account for potential weight regain.
Clinical Best Practices
- Utilize multilevel models for analyzing longitudinal weight data.
- Conduct sensitivity analyses to ensure robustness of findings.
- Maintain transparency in data reporting and analysis methods.
References
